367 related articles for article (PubMed ID: 35274136)
1. Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy.
Mas-Ponte D; McCullough M; Supek F
Clin Sci (Lond); 2022 Mar; 136(5):383-404. PubMed ID: 35274136
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
[TBL] [Abstract][Full Text] [Related]
3. The role of DNA mismatch repair in immunotherapy of human cancer.
He Y; Zhang L; Zhou R; Wang Y; Chen H
Int J Biol Sci; 2022; 18(7):2821-2832. PubMed ID: 35541922
[TBL] [Abstract][Full Text] [Related]
4. A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency.
Tian S; Roepman P; Popovici V; Michaut M; Majewski I; Salazar R; Santos C; Rosenberg R; Nitsche U; Mesker WE; Bruin S; Tejpar S; Delorenzi M; Bernards R; Simon I
J Pathol; 2012 Dec; 228(4):586-95. PubMed ID: 22926706
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
6. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
7. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
Gologan A; Sepulveda AR
Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
[TBL] [Abstract][Full Text] [Related]
11. Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1.
Zhao Y; Miyashita K; Ando T; Kakeji Y; Yamanaka T; Taguchi K; Ushijima T; Oda S; Maehara Y
Gene; 2008 Nov; 423(2):188-93. PubMed ID: 18692554
[TBL] [Abstract][Full Text] [Related]
12. Approaches to diagnose DNA mismatch repair gene defects in cancer.
Peña-Diaz J; Rasmussen LJ
DNA Repair (Amst); 2016 Feb; 38():147-154. PubMed ID: 26708048
[TBL] [Abstract][Full Text] [Related]
13. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
14. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study.
Wang Z; Tang X; Wu X; Yang M; Wang D
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31804673
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair is a double-edged sword in the battle against microsatellite instability.
Miller CJ; Usdin K
Expert Rev Mol Med; 2022 Sep; 24():e32. PubMed ID: 36059110
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks.
Zhao H; Thienpont B; Yesilyurt BT; Moisse M; Reumers J; Coenegrachts L; Sagaert X; Schrauwen S; Smeets D; Matthijs G; Aerts S; Cools J; Metcalf A; Spurdle A; ; Amant F; Lambrechts D
Elife; 2014 Aug; 3():e02725. PubMed ID: 25085081
[TBL] [Abstract][Full Text] [Related]
18. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair in cancer.
Baretti M; Le DT
Pharmacol Ther; 2018 Sep; 189():45-62. PubMed ID: 29669262
[TBL] [Abstract][Full Text] [Related]
20. Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.
Patel SA; Longacre TA; Ladabaum U; Lebensohn A; Lin AY; Haraldsdottir S
Oncologist; 2018 Dec; 23(12):1395-1400. PubMed ID: 30072391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
